Retraction: Experimental infection of mice with avian paramyxovirus serotypes 1 to 9 (PLoS ONE (2011) 6(2) DOI: 10.1371/journal.pone.0016776);Experimental infection of mice with avian paramyxovirus serotypes 1 to 9

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Khattar, Sunil K ^a   Kumar, Sachin ^a   Xiao, Sa ^a   Collins, Peter L ^b   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AVULAVIRUS; BRAIN; BRONCHOPNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL INFECTION; FEMALE; FIBROBLAST; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MONITORING; MOUSE; NONHUMAN; SEROCONVERSION; SEROTYPE; SMALL INTESTINE; SPLEEN; VERO CELL; VIRUS DETECTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CERCOPITHECUS; DISEASE MODEL; IMMUNOLOGY; METABOLISM; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SPECIES DIFFERENCE; VIRAL TROPISM; VIROLOGY; VIRUS LOAD;

ANIMALIA; AVES; AVIAN PARAMYXOVIRUS 4; MUS; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE;

ANIMALS; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED BALB C; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; RESPIRATORY SYSTEM; SPECIES SPECIFICITY; VACCINES, SYNTHETIC; VERO CELLS; VIRAL LOAD; VIRAL TROPISM; VIRUS REPLICATION;

EID: 79951840492     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0244048     Document Type: Erratum

References (61)

1. Lamb R, Parks G, (2007) Paramyxoviridae: the viruses and their replication, In: Knipe DM, Howley PM, Griffin D E, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Philadelphia Lippincott Williams & Wilkins pp. 1449-1496.
2. Rima B, Alexander DJ, Billeter MA, Collins PL, Kingsbury DW, et al. (1995) Family Paramyxoviridae. In: Murphy FA, Fauquet CM, Bishop DHL, Ghabrial SA, Jarvis AW, Martelli GP, Mayo MA, Summers MD, editors. Vienna Springer-Verlag pp. 268-274.
3. Alexander DJ, (2003) Avian paramyxoviruses 2-9; Saif YM eDoPISUPAp, editor. Ames Iowa State University Press.
4. Miller PJ, Afonso CL, Spackman E, Scott MA, Pedersen JC, et al. (2010) Evidence for a new avian paramyxovirus serotype 10 detected in rockhopper penguins from the Falkland Islands. J Virol 84: 11496-11504.
5. Nagai Y, Klenk HD, Rott R, (1976) Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 494-508.
6. de Leeuw O, Peeters B, (1999) Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol 80(Pt 1): 131-136.
7. Krishnamurthy S, Samal SK, (1998) Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence. J Gen Virol 79(Pt 10): 2419-2424.
8. Panda A, Huang Z, Elankumaran S, Rockemann DD, Samal SK, (2004) Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog 36: 1-10.
9. Huang Z, Panda A, Elankumaran S, Govindarajan D, Rockemann DD, et al. (2004) The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol 78: 4176-4184.
10. Rout SN, Samal SK, (2008) The large polymerase protein is associated with the virulence of Newcastle disease virus. J Virol 82: 7828-7836.
11. Miller PJ, Kim LM, Ip HS, Afonso CL, (2009) Evolutionary dynamics of Newcastle disease virus. Virology 391: 64-72.
12. Toyoda T, Sakaguchi T, Imai K, Inocencio NM, Gotoh B, et al. (1987) Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158: 242-247.
13. Dortmans JC, Rottier PJ, Koch G, Peeters BP, (2010) The viral replication complex is associated with the virulence of Newcastle disease virus. J Virol 84: 10113-10120.
14. de Leeuw OS, Koch G, Hartog L, Ravenshorst N, Peeters BP, (2005) Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase protein. J Gen Virol 86: 1759-1769.
15. Estevez C, King D, Seal B, Yu Q, (2007) Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone. Virus Res 129: 182-190.
16. Kumar S, Nayak B, Samuel AS, Xiao S, Collins PL, et al. (2010) Complete genome sequence of avian paramyxovirus-3 strain Wisconsin: evidence for the existence of subgroups within the serotype. Virus Res 149: 78-85.
17. Chang PC, Hsieh ML, Shien JH, Graham DA, Lee MS, et al. (2001) Complete nucleotide sequence of avian paramyxovirus type 6 isolated from ducks. J Gen Virol 82: 2157-2168.
18. Jeon WJ, Lee EK, Kwon JH, Choi KS, (2008) Full-length genome sequence of avain paramyxovirus type 4 isolated from a mallard duck. Virus Genes 37: 342-350.
19. Subbiah M, Xiao S, Collins PL, Samal SK, (2008) Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses. Virus Res 137: 40-48.
20. Kumar S, Nayak B, Collins PL, Samal SK, (2008) Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region. Virus Res 137: 189-197.
21. Nayak B, Kumar S, Collins PL, Samal SK, (2008) Molecular characterization and complete genome sequence of avian paramyxovirus type 4 prototype strain duck/Hong Kong/D3/75. Virol J 5: 124.
22. Samuel AS, Paldurai A, Kumar S, Collins PL, Samal SK, (2010) Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome. PLoS One 5: e9269.
23. Samuel AS, Kumar S, Madhuri S, Collins PL, Samal SK, (2009) Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses. Virus Res 142: 10-18.
24. Xiao S, Paldurai A, Nayak B, Subbiah M, Collins PL, et al. (2009) Complete genome sequence of avian paramyxovirus type 7 (strain Tennessee) and comparison with other paramyxoviruses. Virus Res 145: 80-91.
25. Paldurai A, Subbiah M, Kumar S, Collins PL, Samal SK, (2009) Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78. Virus Res 142: 144-153.
26. Subbiah M, Nayak S, Collins PL, Samal SK, (2010) Complete genome sequences of avian paramyxovirus serotype 2 (APMV-2) strains Bangor, England and Kenya: evidence for the existence of subgroups within serotype 2. Virus Res 152: 85-95.
27. Bankowski RA, Almquist J, Dombrucki J, (1981) Effect of paramyxovirus yucaipa on fertility, hatchability, and poult yield of turkeys. Avian Dis 25: 517-520.
28. Lipkind MA, Weisman Y, Shihmanter E, Shoham D, Aronovici A, (1979) The isolation of yucaipa-like paramyxoviruses from epizootics of a respiratory disease in turkey poultry farms in Israel. Vet Rec 105: 577-578.
29. Tumova B, Robinson JH, Easterday BC, (1979) A hitherto unreported paramyxovirus of turkey. Res in Vet Sci 27: 135-140.
30. Alexander DJ, Pattisson M, Macpherson I, (1983) Avian paramyxovirus of PMV-3 serotype in British turkeys. Avian Pathology 12: 469-482.
31. Nerome K, Nakayama M, Ishida M, Fukumi H, (1978) Isolation of a new avian paramyxovirus from budgerigar (Melopsittacus undulatus). J Gen Virol 38: 293-301.
32. Shortridge KF, Alexander DJ, Collins MS, (1980) Isolation and properties of viruses from poultry in Hong Kong which represent a new (sixth) distinct group of avian paramyxoviruses. J Gen Virol 49: 255-262.
33. Saif YM, Mohan R, Ward L, Senne DA, Panigrahy B, et al. (1997) Natural and experimental infection of turkeys with avian paramyxovirus-7. Avian Dis 41: 326-329.
34. Alexander DJ, Manvell RJ, Frost KM, Pollitt WJ, Welchman D, et al. (1997) Newcastle disease outbreak in pheasants in Great Britain in May 1996. Vet Rec 140: 20-22.
35. Alexander DJ, Allan WH, Parsons G, Collins MS, (1982) Identification of paramyxoviruses isolated from birds dying in quarantine in Great Britain during 1980to 1981. Vet Rec 111: 571-574.
36. Gough RE, Alexander DJ, (1984) Avian paramyxovirus type 4 isolated from a ringed teal (Calonetta leucophrys). Vet Rec 115: 653.
37. Stallknecht DE, Senne DA, Zwank PJ, Shane SM, Kearney MT, (1991) Avian paramyxoviruses from migrating and resident ducks in coastal Louisiana. J Wildl Dis 27: 123-128.
38. Capua I, De Nardi R, Beato MS, Terregino C, Scremin M, et al. (2004) Isolation of an avian paramyxovirus type 9 from migratory waterfowl in Italy. Vet Rec 155: 156.
39. Maldonado A, Arenas A, Tarradas MC, Luque I, Astorga R, et al. (1995) Serological survey for avian paramyxoviruses from wildfowl in aquatic habitats in Andalusia. J Wildl Dis 31: 66-69.
40. Subbiah M, Sa X, Khattar Sunil K, Dias FM, Collins PL, et al. (2010) Pathogenesis of Two Strains of Avian Paramyxovirus Serotype 2, Yucaipa and Bangor, in Chickens and Turkeys. Avian Diseases 54: 1050-1057.
41. Kumar S, Militino Dias F, Nayak B, Collins PL, Samal SK, (2010) Experimental avian paramyxovirus serotype-3 infection in chickens and turkeys. Vet Res 41: 72.
42. DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, et al. (2007) Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A 104: 9788-9793.
43. Carnero E, Li W, Borderia AV, Moltedo B, Moran T, et al. (2009) Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses. J Virol 83: 584-597.
44. Nayak B, Rout SN, Kumar S, Khalil MS, Fouda MM, et al. (2009) Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 4: e6509.
45. Khattar SK, Collins PL, Samal SK, (2010) Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1. Vaccine 28: 3159-3170.
46. Huang Z, Elankumaran S, Yunus AS, Samal SK, (2004) A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol 78: 10054-10063.
47. Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, et al. (2010) Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine 28: 4394-4401.
48. Bukreyev A, Huang Z, Yang L, Elankumaran S, St Claire M, et al. (2005) Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol 79: 13275-13284.
49. Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz SE, et al. (2006) Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J Virol 80: 1130-1139.
50. Romer-Oberdorfer A, Veits J, Helferich D, Mettenleiter TC, (2008) Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 26: 2307-2313.
51. Elankumaran S, Chavan V, Qiao D, Shobana R, Moorkanat G, et al. (2010) Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy. J Virol 84: 3835-3844.
52. Vigil A, Martinez O, Chua MA, Garcia-Sastre A, (2008) Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther 16: 1883-1890.
53. Vigil A, Park MS, Martinez O, Chua MA, Xiao S, et al. (2007) Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res 67: 8285-8292.
54. Zamarin D, Vigil A, Kelly K, Garcia-Sastre A, Fong Y, (2009) Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Ther 16: 796-804.
55. Schirrmacher V, Fournier P, (2009) Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer. Methods Mol Biol 542: 565-605.
56. Alexander DJ, (2009) Newcastle, disease: OIE Terrestrial Manual 2009. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.
57. Lorence RM, Katubig BB, Reichard KW, Reyes HM, Phuangsab A, et al. (1994) Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. Cancer Res 54: 6017-6021.
58. Lorence RM, Reichard KW, Katubig BB, Reyes HM, Phuangsab A, et al. (1994) Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy. J Natl Cancer Inst 86: 1228-1233.
59. Lorence RM, Rood PA, Kelley KW, (1988) Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity. J Natl Cancer Inst 80: 1305-1312.
60. Russell PH, Ozdemir I, (1989) Antibody-forming cell assays of avian paramyxoviruses: the serotype-specific response of mice. J Gen Virol 70(Pt 2): 315-323.
61. Warke A, Stallknecht D, Williams SM, Pritchard N, Mundt E, (2008) Comparative study on the pathogenicity and immunogenicity of wild bird isolates of avian paramyxovirus 2, 4, and 6 in chickens. Avian Pathol 37: 429-434.